Whole Exome Sequencing of Tumors from Young Onset Breast Cancer Women with Germline BRCA1/2 Mutations
The whole exome tumor sequencing data are submitted for the paper "Genomic profiling of young onset gBRCA1/2 breast cancer reveals distinct genomic landscapes and therapeutic implications for PARP and CDK4/6 inhibitor selection." The goal is to understand the somatic genomic landscapes of the young gBRCA1/2 breast cancer women and to investigate how these somatic genomic features are associated with responses to PARP and CDK4/6 inhibitors.